Ischemic heart disease (IHD/ICD10: I20-I25) is the second leading cause of deaths in Japan and accounts for 40% of deaths due to heart diseases. This study aimed to calculate the economic burden of IHD using the cost of illness (COI) method and to identify key factors that drive the change of the economic burden of IHD.
We calculated the cost of illness (COI) every 3 years from 1996 to 2014 using governmental statistics. We then predicted the COI for every 3 years starting from 2017 up to 2029 using the fixed and variable model estimations. Only the estimated future population was used as a variable in the fixed model estimation. By contrast, variable model estimation considered the time trend of health-related indicators over the past 18 years. We derived the COI from the sum of direct and indirect costs (morbidity and mortality).
The past estimation of COI slightly increased from 1493.8 billion yen in 1996 to 1708.3 billion yen in 2014. Future forecasts indicated that it would decrease from 1619.0 billion yen in 2017 to 1220.5 billion yen in 2029.
The past estimation showed that the COI of IHD increased; in the mixed model, the COI was predicted to decrease with the continuing trend of health-related indicators. The COI of IHD in the future projection showed that, although the average age of death increased by social aging, the influence of the number of deaths and mortality cost decreased.
Minister of Health, Labour and Welfare. Vital statistics. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei14/index.html. Accessed 1 Oct 2017.
Rice DP. Estimating the cost of illness. Am J Public Health Nations Health. 1967;7(3):424–40. CrossRef
Crum GE, Rice DP, Hodgson TA. The priceless value of human life. Am J Public Health. 1982;72:536–8. CrossRef
Torres US, Almeida TE, Netinho JG. Increasing hospital admission rates and economic burden for colorectal cancer in Brazil, 1996-2008. Rev Panam Salud Publica. 2010;28(4):244–8. CrossRef
Matsumoto K, Haga K, Hanaoka S, Kitazawa T, Hasegawa T. Costs of illness for major cancers in Japan. JJHM. 2012;13(1):2–6.
Gochi T, Matsumoto K, Haga K, Kitazawa T, Seto K, Fujita S, et al. Estimation of cost of illness (COI) for colon cancer. JJHM. 2015;16(1):2–7.
Hanaoka S, Matsumoto K, Kitazawa T, Seto K, Fujita S, Hasegawa T. Cost of illness of the dementia in Japan, a time trend analysis based on Japanese governmental statistics. JJHM. 2016;17(1):8–13.
Minister of health, Labour and Welfare. Statistics of medical care activities in public health insurances. http://www.mhlw.go.jp/toukei/list/26-19c.html. Accessed 1 Oct 2017.
Minister of Health, Labour and Welfare. Patient survey. http://www.mhlw.go.jp/toukei/list/10-20.html. Accessed 1 Oct 2017.
Ministry of Health, Labour and Welfare. Basic survey on wage structure. http://www.mhlw.go.jp/toukei/list/chinginkouzou.html. Accessed 31 Jan 2018.
Statistics Bureau, Ministry of Internal Affairs and Communications. Labor force survey. http://www.stat.go.jp/data/roudou/index.html. Accesesed 31 Jan 2018.
Economic and Social Research Institute, Cabinet Office, Government of Japan. Satellite account. http://www.esri.cao.go.jp/jp/sna/sonota/satellite/satellite_top.html. Accessed 31 Jan 2018.
Statistics Bureau, Ministry of Internal Affairs and Communications. Population Estimation. http://www.stat.go.jp/data/jinsui/index.html. Accessed 30 June 2017.
National Institute of Population and Social Security Research. Population Projections for Japan. http://www.ipss.go.jp/syoushika/tohkei/suikei07/suikei.html. Accessed 30 June 2017.
Wang K, Li P, Chen L, Kato K, Kobayashi M, Yamauchi K. Impact of the Japanese diagnosis procedure combination-based payment system in Japan. J Med Syst. 2010;34(1):95–100.
Economic Planning Agency (existing Ministry of Economy, Trade and Industry) Economic Research Institute. Is a price of your housework how much? The report about the money evaluation of the gratuitous labor. The Ministry of Finance Printing Bureau (existing National Printing Bureau); 1997.
- Cost of illness of ischemic heart disease in Japan: a time trend and future projections
- BioMed Central